Video Experimental Relacionado
Updated: May 11, 2026
15:17
Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing
Published on: September 25, 2011
14.3K
H2AC14 es un marcador pronóstico novedoso y fiable para el Cáncer Colorrectal
Min Luo1,2, Yue Zhang1, Pei-Feng Li1
1Institute for Translational Medicine, Qingdao University, Qingdao, China.
Medicine
|January 10, 2026
Resumen
La Histona Cluster 2 H2A Family Member C14 (H2AC14) se sobreexpresa en el cáncer colorrectal (CCR) y promueve la metástasis tumoral. Esto sugiere que H2AC14 puede servir como biomarcador diagnóstico para el CCR, ayudando en el tratamiento y el pronóstico.
Videos de Conceptos Relacionados
02:39lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...